![]() |
|||||||||||||
|
Channelrhodopsin-2 |
Channelrhodopsins are a subfamily of opsin proteins that function as light-gated ion channels.1 They serve as sensory photoreceptors in unicellular green algae, controlling phototaxis, i.e. movement in response to light. Expressed in cells of other organisms, they enable the use of light to control intracellular acidity, calcium influx, electrical excitability, and other cellular processes. Three channelrhodopsins are currently known: Channelrhodopsin-1 (ChR1), Channelrhodopsin-2 (ChR2), and Volvox Channelrhodopsin (VChR1). All known Channelrhodopsins are unspecific cation channels, conducting H+, Na+, K+, and Ca2+ ions.
Contents |
Channelrhodopsin-1 was discovered to be a light-activated ion channel in the green algae Chlamydomonas reinhardtii by Georg Nagel and colleagues in 2002.2 Channelrhodopsin-2, which was also isolated from Chlamydomonas reinhardtii, has found widespread use in neuroscience.13 Compared to ChR1, the life time of the conducting state of ChR2 is two times longer. This results in larger stationary currents, but slower kinetics.4
VChR1, which has red-shifted absorption, was discovered in the multicellular alga Volvox.5
Structurally, channelrhodopsins are retinylidene proteins. They are seven-transmembrane proteins like rhodopsin, and contain the light-isomerizable chromophore all-trans-retinal (an aldehyde derivative of vitamin A). The retinal chromophore is covalently linked to the rest of the protein via a protonated Schiff base. Whereas most 7-transmembrane proteins are G protein-coupled receptors that open other ion channels indirectly via second messengers (i.e. they are metabotropic), channelrhodopsins directly form ion channels (i.e. they are ionotropic).1 This makes cellular depolarization extremely fast, robust, and useful for bioengineering and neuroscience applications, including photostimulation.
The C-terminal end of ChR2 extends into the intracellular space and can be replaced by red or yellow fluorescent protein (YFP) without affecting channel function. This kind of fusion constructs can be very useful to visualize the morphology of ChR2 expressing cells.36
ChR2 absorbs blue light with a maximum at 480 nm.7 When the all-trans-retinal complex absorbs a photon, it induces a conformational change from all-trans to 13-cis-retinal. This conformational change introduces a further conformational change in the transmembrane protein, opening the pore to at least 6Å. Within a few milliseconds, the retinal relaxes back to the all-trans form, closing the pore and stopping the flow of ions.1
Channelrhodopsins can be readily expressed in excitable cells such as neurons using a variety of transfection techniques (viral transfection, electroporation, gene gun). The light absorbing pigment retinal is already present in most cells (of vertebrates) in the form of Vitamin A. This makes depolarization of excitable cells very straightforward, useful for many bioengineering and neuroscience applications such as photostimulation of neurons for probing of neural circuits.3 The blue-light sensitve ChR2 and the yellow light-activated chloride pump halorhodopsin together enable multiple-color optical activation and silencing of neural activity with millisecond precision.89 VChR1 from from the colonial alga Volvox carteri absorbs maximally at 535 nm and had been used to stimulate cells with yellow light (580 nm).5 The emerging field of controlling networks of genetically modified cells with light has been termed Optogenetics.
Using fluorescently labeled ChR2, light-stimulated axons and synapses can be identified in intact brain tissue.6 This is useful to study the molecular events during the induction of synaptic plasticity.10 ChR2 has also been used to map long-range connections from one side of the brain to the other.11
The behavior of transgenic animals expressing ChR2 in subpopulations of neurons can be remote-controlled by intense blue light. This has been demonstrated in nematodes, fruit flies, zebrafish, and in mice.1213 Visual function in blind mice can be partially restored by expressing ChR2 in bipolar cells of the retina.14 In the future, ChR2 might also find medical applications, e.g. in certain forms of retinal degeneration or for deep brain stimulation.